|
2009 Journal Article Identification of seven new prostate cancer susceptibility loci through a genome-wide association studyEeles, R. A., Kote-Jarai, Z., Al Olama, A. A., Giles, G. G., Guy, M., Severi, G., Muir, K., Hopper, J. L., Henderson, B. E., Haiman, C. A., Schleutker, J., Hamdy, F. C., Neal, D. E., Donovan, J. L., Stanford, J. L., Ostrander, E. A., Ingles, S. A., John, E. M., Thibodeau, S. N., Schaid, D., Park, J. Y., Spurdle, A., Clements, J., Dickinson, J. L., Maier, C., Vogel, W., Dork, T., Rebbeck, T. R., Cooney, K. A. ... Easton, D. F. (2009). Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nature Genetics, 41 (10), 1116-1121. doi: 10.1038/ng.450 |
|
2009 Journal Article No evidence that GATA3 rs570613 SNP modifies breast cancer riskSpurdle, Amanda B. and Georgia Chenevix-Trench (2009). No evidence that GATA3 rs570613 SNP modifies breast cancer risk. Breast Cancer Research and Treatment, 117 (2), 371-379. doi: 10.1007/s10549-008-0257-1 |
|
2009 Journal Article The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersSpurdle, Amanda B. and G Chenevix-Trench (2009). The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. British Journal of Cancer, 101 (8), 1456-1460. doi: 10.1038/sj.bjc.6605279 |
|
2009 Journal Article Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriersSpurdle, Amanda B. and Georgia Chenevix-Trench (2009). Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Human Molecular Genetics, 18 (22), 4442-4456. doi: 10.1093/hmg/ddp372 |
|
2009 Journal Article Modification of Ovarian Cancer Risk by BRCA1/2-Interacting Genes in a Multicenter Cohort of BRCA1/2 Mutation CarriersSpurdle, Amanda B. and Chenevix-Trench, Georgia (2009). Modification of Ovarian Cancer Risk by BRCA1/2-Interacting Genes in a Multicenter Cohort of BRCA1/2 Mutation Carriers. Cancer Research, 69 (14), 5801-5810. doi: 10.1158/0008-5472.CAN-09-0625 |
|
2009 Journal Article Risk of Estrogen Receptor–Positive and –Negative Breast Cancer and Single–Nucleotide Polymorphism 2q35-rs13387042Spurdle, Amanda B. and Georgia Chenevix-Trench (2009). Risk of Estrogen Receptor–Positive and –Negative Breast Cancer and Single–Nucleotide Polymorphism 2q35-rs13387042. National Cancer Institute. Journal, 101 (14), 1012-1018. doi: 10.1093/jnci/djp167 |
|
2009 Journal Article Polymorphisms in the FGF2 Gene and Risk of Serous Ovarian Cancer: Results From the Ovarian Cancer Association ConsortiumJohnatty, Sharon E., Beesley, Jonathan, Chen, Xiaoqing, Spurdle, Amanda B., DeFazio, Anna, Webb, Penelope M. and Chenevix-Trench, Georgia (2009). Polymorphisms in the FGF2 Gene and Risk of Serous Ovarian Cancer: Results From the Ovarian Cancer Association Consortium. Twin Research and Human Genetics, 12 (3), 269-275. doi: 10.1375/twin.12.3.269 |
|
2009 Journal Article No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriersSpurdle, Amanda B., Deans, AJ, Duffy, David and Georgia Chenevix-Trench (2009). No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment, 115 (2), 307-313. doi: 10.1007/s10549-008-0083-5 |
|
2009 Journal Article The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case–control and family analysisChenevix-Trench, Georgia and Spurdle, Amanda B. (2009). The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case–control and family analysis. Breast Cancer Research and Treatment, 115 (1), 145-150. doi: 10.1007/s10549-008-0045-y |
|
2009 Journal Article No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort studyRebbeck, TR, Antoniou, AC, Llopis, TC, Nevanlinna, H, Aittomaki, K, Simard, J, Spurdle, A B. and Chenevix-Trench, Georgia (2009). No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study. Breast Cancer Research and Treatment, 115 (1), 185-192. doi: 10.1007/s10549-008-0064-8 |
|
2009 Journal Article Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristicsArnold, Sven, Buchanan, Daniel D., Barker, Melissa, Jaskowski, Lesley, Walsh, Michael D., Birney, Genevieve, Woods, Michael O., Hopper, John L., Jenkins, Mark A., Brown, Melissa A., Tavtigian, Sean V., Goldgar, David E., Young, Joanne P. and Spurdle, Amanda B. (2009). Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics. Human Mutation, 30 (5), 757-770. doi: 10.1002/humu.20936 |
|
2009 Journal Article Association of ESR1 gene tagging SNPs with breast cancer riskDunning, A. M., Healey, C. S., Baynes, C., Maia, A. T., Scollen, S., Vega, A., Rodriguez, R., Barbosa-Morais, N. L., Ponder, B. A.J., Low, Y. L., Bingham, S., Haiman, C. A., Le Marchand, L., Broeks, A., Schmidt, M. K., Hopper, J., Southey, M., Beckmann, M. W., Fasching, P. A., Peto, J., Johnson, N., Bojesen, S. E., Nordestgaard, B., Milne, R. L., Benitez, J., Hamann, U., Ko, Y., Schmutzler, R. K., Burwinkel, B. ... Chenevix-Trench, G. (2009). Association of ESR1 gene tagging SNPs with breast cancer risk. Human Molecular Genetics, 18 (6), 1131-1139. doi: 10.1093/hmg/ddn429 |
|
2008 Journal Article Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriersWalker, Logan C., Waddell, Nic, Ten Haaf, Anette, kConFab Investigators, Grimmond, Sean and Spurdle, Amanda B. (2008). Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers. Breast Cancer Research and Treatment, 112 (2), 229-236. doi: 10.1007/s10549-007-9848-5 |
|
2008 Journal Article The RAD51D E233G variant and breast cancer risk: population-based and clinic based family studies of Australian womenDowty, J. G., Lose, F., Jenkins, M. A., Chang, J. H., Chen, X. Q., Beesley, J., Dite, G. S., Southey, M. C., Byrnes, G. B., Tesoriero, A., Giles, G. G., ConFab Investigators, Australian Breast Cancer Family Study, Hooper, J. L. and Spurdle, A. B. (2008). The RAD51D E233G variant and breast cancer risk: population-based and clinic based family studies of Australian women. Breast Cancer Research and Treatment, 112 (1), 35-39. doi: 10.1007/s10549-007-9832-0 |
|
2008 Journal Article Skewed X chromosome inactivation and breast and ovarian cancer status: Evidence for X-linked modifiers of BRCA1Lose, Felicity, Duffy, David L., Kay, Graham F., Cuningham, Kathleen, Kedda, Mary A. and Spurdle, Amanda B. (2008). Skewed X chromosome inactivation and breast and ovarian cancer status: Evidence for X-linked modifiers of BRCA1. Journal of the National Cancer Institute, 100 (21), 1519-1529. doi: 10.1093/jnci/djn345 |
|
2008 Journal Article Lynch syndrome in women less than 50 years of age with endometrial cancerWalsh, Michael D., Young, Joanne, Spurdle, Amanda and Obermair, Andreas (2008). Lynch syndrome in women less than 50 years of age with endometrial cancer. Obstetrics and Gynecology, 112 (4), 943-943. doi: 10.1097/AOG.0b013e3181893013 |
|
2008 Journal Article ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapyJohnatty, Sharon E., Beesley, Jonathan, Paul, Jim, Fereday, Sian, Spurdle, Amanda B., Webb, Penelope M., Byth, Karen, Marsh, Sharon, McLeod, Howard, Harnett, Paul R., Brown, Robert, Defazio, Anna and Chenevix-Trench, Georgia (2008). ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy. Clinical Cancer Research, 14 (17), 5594-5601. doi: 10.1158/1078-0432.CCR-08-0606 |
|
2008 Journal Article Multiple novel prostate cancer predisposition loci confirmed by an international study: The PRACTICAL consortiumKote-Jarai, Zsofia, Easton, Douglas F., Stanford, Janet L., Ostrander, Elaine A., Schleutker, Johanna, Ingles, Sue A., Schaid, Daniel, Thibodeau, Stephen, Dork, Thilo, Neal, David, Cox, Angela, Maier, Christiane, Vogel, Walter, Guy, Michelle, Muir, Kenneth, Lophatananon, Artitaya, Kedda, Mary-Anne, Spurdle, Amanda, Steginga, Suzanne, John, Esther M., Giles, Graham, Hopper, John, Chappuis, Pierre O., Hutter, Pierre, Foulkes, William D., Hamel, Nancy, Salinas, Claudia A., Koopmeiners, Joseph S., Karyadi, Danielle M. ... Eeles, Rosalind A. (2008). Multiple novel prostate cancer predisposition loci confirmed by an international study: The PRACTICAL consortium. Cancer Epidemiology Biomarkers and Prevention, 17 (8), 2052-2061. doi: 10.1158/1055-9965.EPI-08-0317 |
|
2008 Journal Article Colocalisation of predicted exonic splicing enhancers in BRCA2 with reported sequence variantsPettigrew, Christopher A., Wayte, Nicola, Wronski, Ania, Lovelock, Paul K., Spurdle, Amanda B. and Brown, Melissa A. (2008). Colocalisation of predicted exonic splicing enhancers in BRCA2 with reported sequence variants. Breast Cancer Research and Treatment, 110 (2), 227-234. doi: 10.1007/s10549-007-9714-5 |
|
2008 Journal Article BRCA1 and BRCA2 missense variants of high and low clinical significance influence lymphoblastoid cell line post-irradiation gene expressionWaddell, N, Ten Haaf, A, Marsh, A, Johnson, J, Walker, LC, Gongora, M, Brown, M, Grover, P, Girolami, M, Grimmond, S, Chenevix-Trench, G, Spurdle, AB and kConFab Investigators (2008). BRCA1 and BRCA2 missense variants of high and low clinical significance influence lymphoblastoid cell line post-irradiation gene expression. PLoS Genetics, 4 (5) e1000080, Article Number: e1000080. doi: 10.1371/journal.pgen.1000080 |
